You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MRNA Exercise Disclosure
Klinger Shannon Thyme · SEC Form 4 · Filed Sep 3, 2026
Exercise
Reported value range
Not reported
Klinger Shannon Thyme Chief Legal Officer
MRNA
Moderna
MRNA
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
MRNA daily price context
Close on/before transaction
$154.27
Sep 1, 2026
First close after public filing
$145.55
Sep 4, 2026
30-day return after filing
+39.62%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,166 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001682852-26-000167
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$740.3K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Exercise | Sep 1, 2026 | $107.46K |
| Moderna, Inc. MRNA Current | Exercise | Sep 1, 2026 | Not reported |
| Moderna, Inc. MRNA | Sale | Sep 1, 2026 | $485.77K |
| Moderna, Inc. MRNA | Disposition | Sep 1, 2026 | $147.08K |
| Moderna, Inc. MRNA | Exercise | Sep 1, 2026 | $0 |
| Moderna, Inc. MRNA | Exercise | Sep 1, 2026 | $0 |